Concepedia
Statistics
Publications
4
Citations
295
H-Index
Active since
2011
Affiliations
Japan Tobacco (Japan)(Current)
Orphagen Pharmaceuticals (United States)
Noriyoshi Seki is an author at Japan Tobacco (Japan) specializing in drug discovery, medicinal chemistry, and pharmacology.
Publications per year
2011–2021
Discovery of a Highly Potent and Selective MEK Inhibitor: GSK1120212 (JTP-74057 DMSO Solvate)
Hiroyuki Abé, Shinichi Kikuchi, Kazuhide Hayakawa et al. · ACS Medicinal Chemistry Letters · 2011 · 193 citations
Medicine, Oncology, Pharmacology +13
SAR Exploration Guided by LE and Fsp <sup>3</sup> : Discovery of a Selective and Orally Efficacious RORγ Inhibitor
Kazuyuki Hirata, Masayuki Kotoku, Noriyoshi Seki et al. · ACS Medicinal Chemistry Letters · 2015 · 59 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +16
Discovery of Second Generation RORγ Inhibitors Composed of an Azole Scaffold
Masayuki Kotoku, Takaki Maeba, Shingo Fujioka et al. · Journal of Medicinal Chemistry · 2019 · 31 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Discovery of Selective Transforming Growth Factor β Type II Receptor Inhibitors as Antifibrosis Agents
Shohei Miwa, Masahiro Yokota, Yoshifumi Ueyama et al. · ACS Medicinal Chemistry Letters · 2021 · 12 citations · Full text
Life Sciences, Dermatology, Medicinal Chemistry +17
1–4 of 4